Bowel management - no regular intervention prescribed
Looking to the next generation of obesity treatments, combinations of GLP-1 with other entero-pancreatic hormones with complementary actions and/or synergistic potential (such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, and amylin) are under investigation to enhance the WL and cardiometabolic benefits of GLP-1 RA
GLP-1 advantage: Moderate fat content (14-25g depending on flavor) that won't overwhelm your slowed digestion
The program then tracks 17 data points weekly, including body fat percentage, seven body measurements, blood pressure, cholesterol markers, glucose, push-up count, plank hold time, and mile time
Research shows that women with lupus experience the negative effects of obesity at a lower BMI than the general population
Molecular weight: ~4,113.58 Da